Tamtam Try Tamtam free
RWJBarnabas Health logo

RWJBarnabas Health account plan

Health care system

At a glance

RWJBarnabas Health is New Jersey's largest academic health system: 45,000 employees, 5,500 beds, $11,036,784 thousand FY2025 revenue.

RWJ Barnabas Health, Inc. is a not-for-profit, tax-exempt multihospital system based in West Orange, New Jersey, serving eight counties with more than five million residents. It runs 12 acute care hospitals including the Robert Wood Johnson University Hospital academic medical center, three children's hospitals, a pediatric rehabilitation hospital, behavioral health, medical groups, imaging, home care and transplant programmes, in academic partnership with Rutgers. FY2025 total revenue was $11,036,784 thousand (2024: $9,566,595 thousand) with income from operations of $708,886 thousand. In 2025 it had 45,000 employees, 9,900 physicians and 5,500 beds, and ranks as New Jersey's largest private employer. As a not-for-profit it has no shareholders and reports to bondholders.

Business units

Strategic priorities

One system, one family transformation
CEO Mark E. Manigan describes a three-year journey to transform the system; a record seven hospitals earned a Leapfrog A in Fall 2025 and none scored below B.
$1.5 billion oncology investment
Built around Rutgers Cancer Institute: the Jack & Sheryl Morris Cancer Center opened in May 2025, the Melchiorre Cancer Center became fully operational in June 2026 and the Vogel Medical Campus center is due in Q1 2027.
Ambulatory and physician alignment
Growth of the Medical Group and joint ventures, with new multi-specialty hubs in Howell (late 2026 or early 2027) and Morristown (January 2027), and a shift toward employed or tightly aligned physicians.
Englewood Health affiliation
Definitive agreement signed January 5, 2026 for Englewood Health (283 licensed beds, about $1.3 billion revenue) to join the system, with completion expected in Q1 2027.
Workforce retention and clinician well-being
More than 2,420 new team members were added in 2025 and voluntary turnover fell from 17.69% (2022) to 11.82% (2025); EHR simplification and ambient voice technology are used to reduce physician burnout.

Latest results

For the nine months to September 30, 2026, operating revenue rose 17.5% to $9,267,684 thousand and operating income reached $636,186 thousand, a 6.9% margin versus 4.9% a year earlier. Inpatient revenue grew 22.3%, helped by a $526,251 thousand increase from the Medicaid County Option Program, and outpatient revenue rose 11.1%. Operating expenses rose 15.1%, driven by salaries and benefits (+12.1%), new cancer centers, drug costs and County Option tax assessments. Unrestricted cash and investments reached 233.1 days cash on hand; S&P affirmed AA- and Moody's affirmed A1 with the outlook revised to positive. No guidance is given.

Investments and deals

Capital programme
Property and equipment purchases of $782,966 thousand in 2025 and $388,906 thousand through September 2026; the annual report counts $1.46B in capital projects.
Cancer centers
Open commitments of about $256,000 thousand at end 2025 to finish the Melchiorre Cancer Center at Cooperman Barnabas and the Vogel Medical Campus at Monmouth Medical Center.
2026 Plan of Finance
$1,122,395 thousand Series 2026A bonds and $400,000 thousand variable rate demand bonds issued May 7, 2026, partly to defease older bonds and reimburse capital costs.
Englewood Health and joint-venture buyouts
A loan of up to $100,000 thousand to Englewood agreed on August 21, 2026 ahead of its Q1 2027 joining; two medical-group joint ventures fully acquired in 2026 for $28,577 thousand.

Challenges and risks

Dependence on Medicare and Medicaid
The audited statements flag substantial dependence on Medicare and Medicaid reimbursement; Medicaid State Directed Payments of $727,987 thousand were earned in 2025 under a County Option program whose year expired June 30, 2026 with no guarantee of renewal.
Rising costs
Nine-month 2026 operating expenses rose 15.1%, including County Option tax assessments (+$199,847 thousand) and malpractice (+$49,747 thousand).
Labour negotiations
About 22% of employees are under collective bargaining agreements; talks are under way with about 1,600 nurses at Cooperman Barnabas, whose contract expired November 1, 2026, and at Monmouth Southern Campus.
Clinical workforce shortages
Shortages in certain clinical specialties raise labour costs; at Children's Specialized Hospital the CEO says the workforce is inadequate to meet children's needs.

What leadership says

“This is our year to push even further.”

Mark E. Manigan, President and CEO · CEO letter, RWJBarnabas Health 2025 Annual Report

“quality, safety, patient experience. Those are the the drivers. If we do those things well, the the finances will follow.”

Andy Anderson, EVP and Chief Medical and Quality Officer · Becker's Clinical Leadership Podcast, 2 October 2026

“there's no hope to recruit our way out of the access gaps.”

Matt McDonald, President and CEO, Children's Specialized Hospital · Becker's Healthcare Podcast, 11 August 2026

Where a supplier can help

Clinical AI and documentation tools
Tied to clinician well-being: the system already uses ambient voice technology and AI scribes and simplifies its EHR, so documentation, workflow and AI tools that save clinicians time fit its agenda.
Cancer center equipment and operations
Tied to the $1.5 billion oncology investment: equipment, drug supply, scheduling and staffing for the Melchiorre and Vogel centers as they open.
Ambulatory build-out
Tied to the ambulatory priority: fit-out, IT and operating services for the Howell and Morristown hubs and the 630-location joint-venture network.
Integration of Englewood Health
Tied to the Englewood affiliation in Q1 2027: systems, revenue cycle and clinical integration of a 283-bed hospital.
Workforce and cost control
Tied to rising costs and labour shortages: recruitment, retention, training and supply cost management.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like RWJBarnabas Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about RWJBarnabas Health

What is RWJBarnabas Health?

A not-for-profit academic health system in New Jersey with 12 acute care hospitals, children's hospitals, behavioral health, medical groups and ambulatory joint ventures, partnered with Rutgers.

What is RWJBarnabas Health's revenue?

FY2025 total revenue was $11,036,784 thousand. In the nine months to September 30, 2026, operating revenue was $9,267,684 thousand, up 17.5%.

How many employees does RWJBarnabas Health have?

About 45,000 employees in 2025, including 11,700 nurses and 9,900 physicians; it is New Jersey's largest private employer.

Who leads RWJBarnabas Health?

Mark E. Manigan is President and CEO, with John W. Doll as Senior EVP and COO and Frank Pipas as EVP and CFO; Susan C. Reinhard chairs the board.

What is RWJBarnabas Health investing in?

A $1.5 billion oncology investment with three cancer centers, ambulatory hubs in Howell and Morristown, and the Englewood Health affiliation expected in Q1 2027.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)